Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Expanding Usage in the Treatment and Prevention of Surgical Site Infection Propels Povidone Iodine Market Forward, Potential to Lower the Risk of Endometritis in Women to Open up New Revenue Stream, Says TMR

      - Povidone iodine, when compared to chlorhexidine wash and intranasal mupirocin ointment, has the ability to treat MRSA infections because of its fast and better bactericidal action.

      - Povidone iodine manufacturers are diversifying their revenue streams by ramping up manufacturing of topical medication compositions for infection management and wound healing.

      Transparency Market Research Logo

      News provided by

      Transparency Market Research

      Jul 19, 2021, 08:30 ET

      Share this article

      Share this article


      ALBANY, N.Y., July 19, 2021 /PRNewswire/ -- Different areas of a human's oropharyngeal and oral cavities are colonised by a range of viruses, protozoa, fungi, and bacteria. Povidone iodine is regarded as the most efficacious mouthwash, as per a research conducted on the impact of several mouthwashes on oral healthcare. The demand for efficacious oral healthcare solutions is increasing as a result of increased knowledge of oral health, thanks to both private and public initiatives. In addition to that, changes in consumer lifestyles, particularly in developing nations are also likely to support demand for povidone iodine. These factors are likely to propel global povidone iodine market forward in the years to come. It povidone Iodine is commonly used as an antiseptic for the skin, for instance as Betadine. It can also be used for vaginal health and eyes in less concentrated forms. Surgeons make use of it before surgery to sterilise the skin. The most commonly used 10% solution is for disinfecting skin, but it could also further diluted to up to 0.3 %. The surge in the demand for disinfectants and antiseptics for different hygiene applications in the public health sector is expected to drive the global povidone iodine market over the projection period, from 2020 to 2030.

      The global povidone iodine market is expected to grow at a CAGR of 5% over analysis timeframe, from 2020 to 2030 and it is anticipated to reach a value of US$ 256.7 Bn through 2030. During the continuing COVID-19 epidemic, the notion of skin sterilisation becomes more and more important. As a result, betadine antiseptic solutions come with the potential to significantly reduce the concentration of microorganisms on the skin.

      Strong expertise with attention to detail makes our market research reports stand apart. Request a sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11612

      Key Findings of Market Report

      • Potential of PVP-I to Prevent Infection of Surgery Site to Offer Growth Opportunities

      Decolonization of the nasals is a standard technique for controlling and preventing the spread of MRSA (methicillin-resistant staphylococcus aureus) infections. As a result, the gold standard for treating MRSA infections is chlorhexidine wash and intranasal mupirocin ointment. Nonetheless, povidone iodine (PVP-I) as a potential decolonizing agent for treating MRSA infection are supported by failure and resistance associated with these treatment methods. As a result, businesses in the global povidone iodine market are increasing their production capacities in order to improve PVP-I availability.

      Because of the fast, better bactericidal activities of povidone iodine in comparison with chlorhexidine wash and intranasal ointment, it also hold immense promise for the treatment of MRSA infections. The usefulness of PVP-I to reduce the likelihood of surgery site (SSI's) infection in orthopaedic operations is increased by businesses in the povidone iodine industry.

      We deliver what we promise; Get our premium research report on Povidone Iodine Market with In-depth research, accurate analysis at https://www.transparencymarketresearch.com/checkout.php?rep_id=11612&ltype=S

      • Expanding Usage in Gynecological Issues to Accentuate Demand for Povidone Iodine

      Antiseptic compositions have received a lot of attention as efficient vaginal antiseptics. Even povidone iodine, which is present in metronidazole and cetrimide, has been proven to lower the likelihood of endometritis in women following delivery. Povidone iodine 1% has a good chance of becoming one of the most successful treatments for endometritis prophylaxis. Firms in the global povidone iodine market, on the other hand, are expanding the use of PVP-I to avoid secondary outcomes such as fever associated with endometritis and postoperative wound infection in women. These advantages are likely to support expansion of the global povidone iodine market in the years to come.

      Povidone Iodine Market: Growth Drivers

      • In topical medication formulations, there is a rising need for a mix of anti-infectious treatment and healing-promoting moisturization. As a result, producers are ramping up manufacturing of povidone iodine liposome hydrogel, which may be used for both moist and antiseptic therapy.
      • The demand for povidone iodine infused dental floss has been fueled by an unacceptably increasing prevalence of periodontal disease amongst people all over the world. This is a common occurrence in Asian countries, which is why the sale of povidone iodine in the Asia Pacific region is projected to skyrocket in the years to come.

      Request for covid19 Impact Analysis at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11612

      Povidone Iodine Market: Key Competitors

      • Sumitomo Seika Chemicals Co. Ltd
      • Evonik Industries AG
      • Sanyo Chemical Industries
      • Nippon Shokubai Co., Ltd
      • KAO Corporation
      • LG Chem Ltd.

      Povidone Iodine Market: Segmentation

      Application

      • Skin Sterilization
      • Infection Prevention
      • Instrument Sterilization

      E-commerce to Become Growth Back Bone of Chemical & Materials Market. Get a 360 Degree Peek into the Entire Chemical & Materials Industry @ https://www.transparencymarketresearch.com/chemical-market-reports-2.html

      About Transparency Market Research

      TMR has a track record to provide ace market research solutions that has earned us the trust of our clients for their business intelligence needs. Serving 13 industry verticals with a database of over 1,000 reports and 1 million + data points, our expanse to provide market research solutions is exceptional. We deep dive for a thorough understanding of the subject, gather precise information, and then analyze it to present solutions that are par excellence.

      Contact
      Mr Rohit Bhisey
      Transparency Market Research
      State Tower,
      90 State Street,                                                                                                                
      Suite 700,
      Albany NY - 12207
      United States
      USA - Canada Toll Free: 866-552-3453
      Email: [email protected]  
      Blog: https://tmrblog.com/   
      Press Release Source: https://www.transparencymarketresearch.com/pressrelease/povidone-iodine-market.htm

      SOURCE Transparency Market Research

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.